Bridges Investment Management Inc Amgen Inc Transaction History

Bridges Investment Management Inc

  • $7.07 Billion
  • Q3 2024

A detailed history of Bridges Investment Management Inc transactions in Amgen Inc stock. As of the latest transaction made, Bridges Investment Management Inc holds 93,542 shares of AMGN stock, worth $24.6 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares
93,542
Previous 94,503 1.02%
Holding current value
$24.6 Million
Previous $29.5 Million 2.08%
% of portfolio
0.43%
Previous 0.45%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024
SELL
$309.38 - $337.38 $297,314 - $324,222
-961 Reduced 1.02%
93,542 $30.1 Million
Q2 2024

Aug 12, 2024
BUY
$262.75 - $319.31 $16.8 Million - $20.4 Million
63,804 Added 207.84%
94,503 $29.5 Million
Q1 2024

Apr 25, 2024
BUY
$268.87 - $324.56 $665,722 - $803,610
2,476 Added 8.77%
30,699 $8.73 Million
Q4 2023

Jan 23, 2024
SELL
$255.7 - $288.46 $536,970 - $605,766
-2,100 Reduced 6.93%
28,223 $8.13 Million
Q3 2023

Oct 24, 2023
SELL
$218.65 - $271.46 $209,685 - $260,330
-959 Reduced 3.07%
30,323 $8.15 Million
Q2 2023

Jul 07, 2023
SELL
$214.27 - $253.37 $312,834 - $369,920
-1,460 Reduced 4.46%
31,282 $6.95 Million
Q1 2023

Apr 28, 2023
SELL
$225.79 - $275.2 $46,964 - $57,241
-208 Reduced 0.63%
32,742 $7.92 Million
Q4 2022

Feb 13, 2023
BUY
$229.03 - $291.01 $506,385 - $643,423
2,211 Added 7.19%
32,950 $8.65 Million
Q3 2022

Oct 21, 2022
SELL
$224.46 - $253.15 $192,811 - $217,455
-859 Reduced 2.72%
30,739 $6.93 Million
Q2 2022

Jul 12, 2022
SELL
$230.71 - $256.74 $21,686 - $24,133
-94 Reduced 0.3%
31,598 $7.69 Million
Q1 2022

Apr 08, 2022
SELL
$219.27 - $242.57 $31,794 - $35,172
-145 Reduced 0.46%
31,692 $7.66 Million
Q4 2021

Feb 01, 2022
BUY
$198.88 - $227.6 $829,329 - $949,092
4,170 Added 15.07%
31,837 $7.16 Million
Q3 2021

Nov 12, 2021
BUY
$212.27 - $248.7 $24,411 - $28,600
115 Added 0.42%
27,667 $5.88 Million
Q2 2021

Jul 19, 2021
SELL
$233.58 - $259.14 $678,549 - $752,801
-2,905 Reduced 9.54%
27,552 $6.72 Million
Q1 2021

May 05, 2021
SELL
$221.91 - $258.6 $2.58 Million - $3 Million
-11,610 Reduced 27.6%
30,457 $7.58 Million
Q4 2020

Feb 12, 2021
SELL
$216.38 - $257.67 $929,135 - $1.11 Million
-4,294 Reduced 9.26%
42,067 $9.67 Million
Q3 2020

Nov 12, 2020
BUY
$234.65 - $260.95 $202,033 - $224,677
861 Added 1.89%
46,361 $11.8 Million
Q2 2020

Aug 10, 2020
SELL
$197.81 - $242.74 $408,082 - $500,772
-2,063 Reduced 4.34%
45,500 $10.7 Million
Q1 2020

May 12, 2020
SELL
$182.24 - $241.7 $769,781 - $1.02 Million
-4,224 Reduced 8.16%
47,563 $9.64 Million
Q4 2019

Feb 18, 2020
SELL
$189.21 - $243.2 $453,536 - $582,950
-2,397 Reduced 4.42%
51,787 $12.5 Million
Q3 2019

Nov 12, 2019
BUY
$174.11 - $208.62 $205,623 - $246,380
1,181 Added 2.23%
54,184 $10.5 Million
Q2 2019

Aug 07, 2019
SELL
$166.7 - $195.41 $77,515 - $90,865
-465 Reduced 0.87%
53,003 $9.77 Million
Q1 2019

May 01, 2019
BUY
$180.87 - $203.88 $53,899 - $60,756
298 Added 0.56%
53,468 $10.2 Million
Q4 2018

Feb 11, 2019
BUY
$178.4 - $208.25 $758,556 - $885,479
4,252 Added 8.69%
53,170 $10.4 Million
Q3 2018

Nov 15, 2018
BUY
$185.29 - $208.89 $75,042 - $84,600
405 Added 0.83%
48,918 $10.1 Million
Q2 2018

Aug 15, 2018
SELL
$166.05 - $186.51 $26,900 - $30,214
-162 Reduced 0.33%
48,513 $8.96 Million
Q1 2018

Apr 25, 2018
BUY
$169.43 - $198.0 $277,865 - $324,720
1,640 Added 3.49%
48,675 $8.3 Million
Q4 2017

Feb 09, 2018
SELL
$168.79 - $188.59 $1.46 Million - $1.63 Million
-8,653 Reduced 15.54%
47,035 $8.18 Million
Q3 2017

Oct 05, 2017
BUY
$167.29 - $191.0 $2.76 Million - $3.15 Million
16,477 Added 42.02%
55,688 $10.4 Million
Q3 2017

Oct 02, 2017
BUY
$167.29 - $191.0 $6.56 Million - $7.49 Million
39,211
39,211 $7.31 Million

Others Institutions Holding AMGN

# of Institutions
3,125
Shares Held
409M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Bridges Investment Management Inc Portfolio

Follow Bridges Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridges Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bridges Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email